DrugPatentWatch Database Preview
Drugs in MeSH Category Bone Density Conservation Agents
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | TAMOXIFEN CITRATE | tamoxifen citrate | TABLET;ORAL | 074504-001 | Apr 28, 2003 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Apotex | TAMOXIFEN CITRATE | tamoxifen citrate | TABLET;ORAL | 090878-002 | Sep 23, 2011 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Rising | TOREMIFENE CITRATE | toremifene citrate | TABLET;ORAL | 208813-001 | Dec 4, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Apotex Inc | RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 090877-003 | Jun 10, 2014 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
